2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| ProQuest Investments IV, L.P. | 10% Owner | 1,242,031 | Nov 29, 2017 |
| ProQuest Associates IV LLC | 10% Owner | 1,242,031 | Nov 29, 2017 |
| Moorin Jay | 10% Owner | 1,242,031 | Nov 29, 2017 |
| Schreiber Alain | 10% Owner | 1,242,031 | Nov 29, 2017 |
| Belldegrun Arie | — | 160,000 | Sep 16, 2022 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | Feb 27, 2026 | Robinson James A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2026 | Feb 19, 2026 | Barrett Elizabeth A. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2026 | Feb 11, 2026 | Smith Jason Drew | General Counsel | Sell | 42.5 | -7,479 | -4.47% | ✗ | $147.3K |
| Feb 3, 2026 | Feb 4, 2026 | Schoenberg Mark | Chief Medical Officer | Sell | 42.5 | -7,373 | -4.84% | ✗ | $145.2K |
| Jan 31, 2026 | Feb 3, 2026 | Schoenberg Mark | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2026 | Feb 3, 2026 | Degnan Chris | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 26, 2025 | Dec 1, 2025 | Holden Stuart | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 26, 2025 | Dec 1, 2025 | BUTITTA CYNTHIA M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 26, 2025 | Dec 1, 2025 | Robinson James A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 26, 2025 | Dec 1, 2025 | WEN LEANA | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 26, 2025 | Dec 1, 2025 | Wildman Daniel George | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 19, 2025 | Nov 20, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | 30.0 | -10,000 | -6.71% | ✓ | $250K |
| Oct 8, 2025 | Oct 9, 2025 | Degnan Chris | CFO | Sell | 46.3 | -2,203 | -49.14% | ✗ | $37.1K |
| Sep 7, 2025 | Sep 9, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | 48.8 | -871 | -0.58% | ✗ | $16.6K |
| Sep 7, 2025 | Sep 9, 2025 | Smith Jason Drew | General Counsel | Sell | 46.3 | -1,520 | -3.39% | ✗ | $29K |
| Aug 26, 2025 | Aug 27, 2025 | Wildman Daniel George | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 26, 2025 | Aug 27, 2025 | Robinson James A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 26, 2025 | Aug 27, 2025 | Holden Stuart | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 26, 2025 | Aug 27, 2025 | BUTITTA CYNTHIA M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 26, 2025 | Aug 27, 2025 | WEN LEANA | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 26, 2025 | Aug 27, 2025 | Belldegrun Arie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 11, 2025 | Aug 13, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | 22.5 | -10,000 | -6.32% | ✗ | $176.9K |
| Jul 28, 2025 | Jul 30, 2025 | Barrett Elizabeth A. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 28, 2025 | Jul 30, 2025 | Smith Jason Drew | General Counsel | Sell | 42.5 | -7,522 | -15.35% | ✗ | $144K |
| Jul 28, 2025 | Jul 30, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | 42.5 | -5,149 | -3.15% | ✗ | $98.6K |
| Jun 8, 2025 | Jun 11, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | 46.3 | -5,162 | -3.26% | ✗ | $38K |
| Jan 31, 2025 | Feb 4, 2025 | Schoenberg Mark | Chief Medical Officer | Sell | 42.5 | -4,551 | -1.02% | ✗ | $50.7K |
| Jan 31, 2025 | Feb 4, 2025 | Smith Jason Drew | General Counsel | Sell | 42.5 | -7,379 | -7.68% | ✗ | $82.2K |
| Jan 31, 2025 | Feb 4, 2025 | Barrett Elizabeth A. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2024 | Oct 9, 2024 | Degnan Chris | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 9, 2024 | Degnan Chris | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 9, 2024 | Sep 12, 2024 | Schoenberg Mark | Chief Medical Officer | Sell | 48.8 | -859 | -0.59% | ✗ | $11.2K |
| Sep 9, 2024 | Sep 12, 2024 | Smith Jason Drew | General Counsel | Sell | 46.3 | -1,521 | -5.69% | ✗ | $19.9K |
| Sep 9, 2024 | Sep 12, 2024 | Kim Dong | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 6, 2024 | Aug 8, 2024 | Belldegrun Arie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 6, 2024 | Aug 8, 2024 | Cohen Fred E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 6, 2024 | Aug 8, 2024 | Wildman Daniel George | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 6, 2024 | Aug 8, 2024 | Holden Stuart | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 6, 2024 | Aug 8, 2024 | Robinson James A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 6, 2024 | Aug 8, 2024 | WEN LEANA | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 6, 2024 | Aug 8, 2024 | BUTITTA CYNTHIA M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2024 | Jun 11, 2024 | Schoenberg Mark | Chief Medical Officer | Sell | 42.5 | -5,153 | -3.45% | ✗ | $67.4K |
| Mar 18, 2024 | Mar 20, 2024 | Schoenberg Mark | Chief Medical Officer | Sell | 22.5 | -12,000 | -7.92% | ✗ | $168.6K |
| Jan 31, 2024 | Feb 12, 2024 | Kim Dong | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 25, 2022 | Feb 12, 2024 | Kim Dong | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | Smith Jason Drew | General Counsel | Sell | 22.5 | -4,993 | -7.42% | ✗ | $78.8K |
| Feb 1, 2024 | Feb 5, 2024 | Schoenberg Mark | Chief Medical Officer | Sell | 32.5 | -3,789 | -0.83% | ✗ | $59.8K |
| Jan 31, 2024 | Feb 2, 2024 | Smith Jason Drew | General Counsel | Sell | 42.5 | -4,993 | -7.42% | ✗ | $78.6K |
| Jan 31, 2024 | Feb 2, 2024 | Schoenberg Mark | Chief Medical Officer | Sell | 45.0 | -3,789 | -0.83% | ✗ | $59.6K |
| Jan 31, 2024 | Feb 2, 2024 | Kim Dong | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2024 | Feb 2, 2024 | Barrett Elizabeth A. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2023 | Sep 8, 2023 | Belldegrun Arie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2023 | Sep 8, 2023 | BUTITTA CYNTHIA M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2023 | Sep 8, 2023 | Cohen Fred E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2023 | Sep 8, 2023 | Wildman Daniel George | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2023 | Sep 8, 2023 | Holden Stuart | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2023 | Sep 8, 2023 | Robinson James A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2023 | Sep 8, 2023 | WEN LEANA | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2023 | Sep 8, 2023 | Smith Jason Drew | General Counsel | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2023 | Sep 8, 2023 | Kim Dong | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 7, 2023 | Sep 8, 2023 | Schoenberg Mark | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 31, 2023 | Sep 5, 2023 | Smith Jason Drew | General Counsel | Sell | 42.5 | -3,800 | -17.11% | ✗ | $68.4K |
| Jul 26, 2023 | Jul 28, 2023 | Cohen Fred E | Director | Neutral | 90.0 | +69,339 | 100.00% | ✗ | - |
| Jul 25, 2023 | Jul 28, 2023 | Robinson James A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 25, 2023 | Jul 27, 2023 | Robinson James A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 27, 2023 | Robinson James A. Jr. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 8, 2023 | Jun 9, 2023 | Schoenberg Mark | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2022 | Feb 28, 2023 | Nussbaum Ran | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 21, 2022 | Feb 28, 2023 | Nussbaum Ran | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 16, 2022 | Feb 28, 2023 | Nussbaum Ran | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2023 | Feb 2, 2023 | Barrett Elizabeth A. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2023 | Feb 2, 2023 | Kim Dong | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2023 | Feb 2, 2023 | Smith Jason Drew | General Counsel | Sell | 46.3 | -1,636 | -5.82% | ✗ | $16.6K |
| Jan 31, 2023 | Feb 2, 2023 | Schoenberg Mark | Chief Medical Officer | Sell | 51.3 | -1,900 | -0.43% | ✗ | $19.2K |
| Jan 20, 2023 | Jan 23, 2023 | Schoenberg Mark | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 9, 2022 | Wildman Daniel George | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 8, 2022 | Nov 9, 2022 | Wildman Daniel George | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 31, 2022 | Nov 2, 2022 | Schoenberg Mark | Chief Medical Officer | Sell | 47.5 | -258 | -1.07% | ✗ | $3.1K |
| Oct 21, 2022 | Oct 25, 2022 | Nussbaum Ran | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 14, 2022 | Sep 16, 2022 | Belldegrun Arie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 12, 2022 | WEN LEANA | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 8, 2022 | Sep 12, 2022 | WEN LEANA | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 31, 2022 | Sep 2, 2022 | Belldegrun Arie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 31, 2022 | Sep 2, 2022 | Smith Jason Drew | General Counsel | Sell | 46.3 | -3,606 | -22.85% | ✗ | $26K |
| Jun 6, 2022 | Aug 25, 2022 | Nussbaum Ran | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 31, 2022 | Aug 25, 2022 | Schoenberg Mark | Chief Medical Officer | Sell | 47.5 | -259 | -1.08% | ✗ | $2K |
| Jun 8, 2022 | Jun 10, 2022 | Belldegrun Arie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2022 | Jun 10, 2022 | BUTITTA CYNTHIA M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2022 | Jun 10, 2022 | Cohen Fred E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2022 | Jun 10, 2022 | Holden Stuart | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2022 | Jun 10, 2022 | Nussbaum Ran | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 30, 2022 | May 3, 2022 | Schoenberg Mark | Chief Medical Officer | Sell | 47.5 | -254 | -1.07% | ✗ | $1.7K |
| Mar 25, 2022 | Mar 29, 2022 | Kim Dong | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 29, 2022 | Kim Dong | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 31, 2022 | Feb 2, 2022 | Smith Jason Drew | General Counsel | Sell | 47.5 | -414 | -5.27% | ✗ | $3.1K |
| Jan 31, 2022 | Feb 2, 2022 | Henderson Molly | CFO | Sell | 47.5 | -331 | -5.93% | ✗ | $2.5K |
| Jan 31, 2022 | Feb 2, 2022 | Schoenberg Mark | Chief Medical Officer | Sell | 46.3 | -1,374 | -2.93% | ✗ | $10.4K |
| Jan 31, 2022 | Feb 2, 2022 | Barrett Elizabeth A. | CEO | Sell | 42.5 | -8,195 | -1.33% | ✗ | $62.1K |
| Jan 26, 2022 | Jan 28, 2022 | Schoenberg Mark | Chief Medical Officer | Sell | 52.5 | -111 | -0.50% | ✗ | $898 |
| Jan 3, 2022 | Jan 7, 2022 | Barrett Elizabeth A. | CEO | Sell | 40.0 | -46,968 | -13.61% | ✗ | $429.8K |